APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Bioartificial Organ Manufacturing

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Bioartificial Organ Manufacturing Market Analysis and Forecast 2026-2032

Report ID 174078690217 January 2026208 pages

Choose your research edition.

Industry ResearchBioartificial Organ Manufacturing Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Bioartificial Organ Manufacturing Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Bioartificial Organ Manufacturing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bioartificial Organ Manufacturing Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Bioartificial Organ Manufacturing Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Bioartificial Organ Manufacturing market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Bioartificial Organ Manufacturing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Bioartificial Organ Manufacturing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Bioartificial Organ Manufacturing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Bioartificial Organ Manufacturing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Bioartificial Organ Manufacturing include B. Braun, Boston Scientific Corporation, ABIOMED, Asahi Kasei Corporation, Berlin Heart, CARMAT, Jarvik Heart, SynCardia Systems and Nipro Europe Group Companies, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Bioartificial Organ Manufacturing, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Bioartificial Organ Manufacturing, also provides the revenue of main regions and countries. Of the upcoming market potential for Bioartificial Organ Manufacturing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Bioartificial Organ Manufacturing revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Bioartificial Organ Manufacturing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Bioartificial Organ Manufacturing revenue, projected growth trends, production technology, application and end-user industry.

Bioartificial Organ Manufacturing Segment by Company

B. Braun

Boston Scientific Corporation

ABIOMED

Asahi Kasei Corporation

Berlin Heart

CARMAT

Jarvik Heart

SynCardia Systems

Nipro Europe Group Companies

Organovo Holdings

NexImmune

Diabeloop

Admetsys

Defymed

Pancreum

Beta Bionics

Integra LifeSciences

Wake Forest Institute for Regenerative Medicine (WFIRM)

Bioartificial Organ Manufacturing Segment by Type

Semi-automatic

Fully Automatic

Manual

Bioartificial Organ Manufacturing Segment by Application

Hospitals

Research Institutes

Laboratory

Others

Bioartificial Organ Manufacturing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bioartificial Organ Manufacturing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bioartificial Organ Manufacturing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bioartificial Organ Manufacturing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Bioartificial Organ Manufacturing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Bioartificial Organ Manufacturing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Bioartificial Organ Manufacturing revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Bioartificial Organ Manufacturing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Semi-automatic Major Player Table 3. Fully Automatic Major Player Table 4. Manual Major Player Table 5. Global Bioartificial Organ Manufacturing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospitals Major Player Table 7. Research Institutes Major Player Table 8. Laboratory Major Player Table 9. Others Major Player Table 10. Bioartificial Organ Manufacturing Industry Trends Table 11. Bioartificial Organ Manufacturing Industry Drivers Table 12. Bioartificial Organ Manufacturing Industry Opportunities and Challenges Table 13. Bioartificial Organ Manufacturing Industry Restraints Table 14. Global Bioartificial Organ Manufacturing Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Bioartificial Organ Manufacturing Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Bioartificial Organ Manufacturing Market Share by Region (2021-2026) Table 17. Global Bioartificial Organ Manufacturing Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Bioartificial Organ Manufacturing Market Share by Region (2027-2032) Table 19. Global Bioartificial Organ Manufacturing Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Bioartificial Organ Manufacturing Revenue Market Share by Players (2021-2026) Table 21. Global Bioartificial Organ Manufacturing Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Bioartificial Organ Manufacturing Key Players Headquarters & Area Served Table 23. Global Bioartificial Organ Manufacturing Players, Product Type & Application Table 24. Global Bioartificial Organ Manufacturing Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Bioartificial Organ Manufacturing by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Bioartificial Organ Manufacturing Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Bioartificial Organ Manufacturing Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Bioartificial Organ Manufacturing Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Bioartificial Organ Manufacturing Revenue Market Share by Type (2021-2026) Table 31. Global Bioartificial Organ Manufacturing Revenue Market Share by Type (2027-2032) Table 32. Global Bioartificial Organ Manufacturing Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Bioartificial Organ Manufacturing Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Bioartificial Organ Manufacturing Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Bioartificial Organ Manufacturing Revenue Market Share by Application (2021-2026) Table 36. Global Bioartificial Organ Manufacturing Revenue Market Share by Application (2027-2032) Table 37. B. Braun Company Information Table 38. B. Braun Business Overview Table 39. B. Braun Bioartificial Organ Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. B. Braun Bioartificial Organ Manufacturing Product Portfolio Table 41. B. Braun Recent Development Table 42. Boston Scientific Corporation Company Information Table 43. Boston Scientific Corporation Business Overview Table 44. Boston Scientific Corporation Bioartificial Organ Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Boston Scientific Corporation Bioartificial Organ Manufacturing Product Portfolio Table 46. Boston Scientific Corporation Recent Development Table 47. ABIOMED Company Information Table 48. ABIOMED Business Overview Table 49. ABIOMED Bioartificial Organ Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. ABIOMED Bioartificial Organ Manufacturing Product Portfolio Table 51. ABIOMED Recent Development Table 52. Asahi Kasei Corporation Company Information Table 53. Asahi Kasei Corporation Business Overview Table 54. Asahi Kasei Corporation Bioartificial Organ Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Asahi Kasei Corporation Bioartificial Organ Manufacturing Product Portfolio Table 56. Asahi Kasei Corporation Recent Development Table 57. Berlin Heart Company Information Table 58. Berlin Heart Business Overview Table 59. Berlin Heart Bioartificial Organ Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Berlin Heart Bioartificial Organ Manufacturing Product Portfolio Table 61. Berlin Heart Recent Development Table 62. CARMAT Company Information Table 63. CARMAT Business Overview Table 64. CARMAT Bioartificial Organ Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. CARMAT Bioartificial Organ Manufacturing Product Portfolio Table 66. CARMAT Recent Development Table 67. Jarvik Heart Company Information Table 68. Jarvik Heart Business Overview Table 69. Jarvik Heart Bioartificial Organ Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Jarvik Heart Bioartificial Organ Manufacturing Product Portfolio Table 71. Jarvik Heart Recent Development Table 72. SynCardia Systems Company Information Table 73. SynCardia Systems Business Overview Table 74. SynCardia Systems Bioartificial Organ Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. SynCardia Systems Bioartificial Organ Manufacturing Product Portfolio Table 76. SynCardia Systems Recent Development Table 77. Nipro Europe Group Companies Company Information Table 78. Nipro Europe Group Companies Business Overview Table 79. Nipro Europe Group Companies Bioartificial Organ Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Nipro Europe Group Companies Bioartificial Organ Manufacturing Product Portfolio Table 81. Nipro Europe Group Companies Recent Development Table 82. Organovo Holdings Company Information Table 83. Organovo Holdings Business Overview Table 84. Organovo Holdings Bioartificial Organ Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Organovo Holdings Bioartificial Organ Manufacturing Product Portfolio Table 86. Organovo Holdings Recent Development Table 87. NexImmune Company Information Table 88. NexImmune Business Overview Table 89. NexImmune Bioartificial Organ Manufacturing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. NexImmune Bioartificial Organ Manufacturing Product Portfolio Table 91. NexImmune Recent Development Table 92. Diabeloop Company Information Table 93. Diabeloop Business Overview Table 94. Diabeloop Bioartificial Organ Manufacturing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Diabeloop Bioartificial Organ Manufacturing Product Portfolio Table 96. Diabeloop Recent Development Table 97. Admetsys Company Information Table 98. Admetsys Business Overview Table 99. Admetsys Bioartificial Organ Manufacturing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Admetsys Bioartificial Organ Manufacturing Product Portfolio Table 101. Admetsys Recent Development Table 102. Defymed Company Information Table 103. Defymed Business Overview Table 104. Defymed Bioartificial Organ Manufacturing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Defymed Bioartificial Organ Manufacturing Product Portfolio Table 106. Defymed Recent Development Table 107. Pancreum Company Information Table 108. Pancreum Business Overview Table 109. Pancreum Bioartificial Organ Manufacturing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Pancreum Bioartificial Organ Manufacturing Product Portfolio Table 111. Pancreum Recent Development Table 112. Beta Bionics Company Information Table 113. Beta Bionics Business Overview Table 114. Beta Bionics Bioartificial Organ Manufacturing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. Beta Bionics Bioartificial Organ Manufacturing Product Portfolio Table 116. Beta Bionics Recent Development Table 117. Integra LifeSciences Company Information Table 118. Integra LifeSciences Business Overview Table 119. Integra LifeSciences Bioartificial Organ Manufacturing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. Integra LifeSciences Bioartificial Organ Manufacturing Product Portfolio Table 121. Integra LifeSciences Recent Development Table 122. Wake Forest Institute for Regenerative Medicine (WFIRM) Company Information Table 123. Wake Forest Institute for Regenerative Medicine (WFIRM) Business Overview Table 124. Wake Forest Institute for Regenerative Medicine (WFIRM) Bioartificial Organ Manufacturing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. Wake Forest Institute for Regenerative Medicine (WFIRM) Bioartificial Organ Manufacturing Product Portfolio Table 126. Wake Forest Institute for Regenerative Medicine (WFIRM) Recent Development Table 127. North America Bioartificial Organ Manufacturing Revenue by Type (2021-2026) & (US$ Million) Table 128. North America Bioartificial Organ Manufacturing Revenue by Type (2027-2032) & (US$ Million) Table 129. North America Bioartificial Organ Manufacturing Revenue by Application (2021-2026) & (US$ Million) Table 130. North America Bioartificial Organ Manufacturing Revenue by Application (2027-2032) & (US$ Million) Table 131. North America Bioartificial Organ Manufacturing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 132. North America Bioartificial Organ Manufacturing Revenue by Country (2021-2026) & (US$ Million) Table 133. North America Bioartificial Organ Manufacturing Revenue by Country (US$ Million) & (2027-2032) Table 134. Europe Bioartificial Organ Manufacturing Revenue by Type (2021-2026) & (US$ Million) Table 135. Europe Bioartificial Organ Manufacturing Revenue by Type (2027-2032) & (US$ Million) Table 136. Europe Bioartificial Organ Manufacturing Revenue by Application (2021-2026) & (US$ Million) Table 137. Europe Bioartificial Organ Manufacturing Revenue by Application (2027-2032) & (US$ Million) Table 138. Europe Bioartificial Organ Manufacturing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 139. Europe Bioartificial Organ Manufacturing Revenue by Country (2021-2026) & (US$ Million) Table 140. Europe Bioartificial Organ Manufacturing Revenue by Country (US$ Million) & (2027-2032) Table 141. China Bioartificial Organ Manufacturing Revenue by Type (2021-2026) & (US$ Million) Table 142. China Bioartificial Organ Manufacturing Revenue by Type (2027-2032) & (US$ Million) Table 143. China Bioartificial Organ Manufacturing Revenue by Application (2021-2026) & (US$ Million) Table 144. China Bioartificial Organ Manufacturing Revenue by Application (2027-2032) & (US$ Million) Table 145. Asia Bioartificial Organ Manufacturing Revenue by Type (2021-2026) & (US$ Million) Table 146. Asia Bioartificial Organ Manufacturing Revenue by Type (2027-2032) & (US$ Million) Table 147. Asia Bioartificial Organ Manufacturing Revenue by Application (2021-2026) & (US$ Million) Table 148. Asia Bioartificial Organ Manufacturing Revenue by Application (2027-2032) & (US$ Million) Table 149. Asia Bioartificial Organ Manufacturing Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 150. Asia Bioartificial Organ Manufacturing Revenue by Region (US$ Million) & (2021-2026) Table 151. Asia Bioartificial Organ Manufacturing Revenue by Region (US$ Million) & (2027-2032) Table 152. SAMEA Bioartificial Organ Manufacturing Revenue by Type (2021-2026) & (US$ Million) Table 153. SAMEA Bioartificial Organ Manufacturing Revenue by Type (2027-2032) & (US$ Million) Table 154. SAMEA Bioartificial Organ Manufacturing Revenue by Application (2021-2026) & (US$ Million) Table 155. SAMEA Bioartificial Organ Manufacturing Revenue by Application (2027-2032) & (US$ Million) Table 156. SAMEA Bioartificial Organ Manufacturing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 157. SAMEA Bioartificial Organ Manufacturing Revenue by Country (2021-2026) & (US$ Million) Table 158. SAMEA Bioartificial Organ Manufacturing Revenue by Country (US$ Million) & (2027-2032) Table 159. Research Programs/Design for This Report Table 160. Authors List of This Report Table 161. Secondary Sources Table 162. Primary Sources List of Figures Figure 1. Bioartificial Organ Manufacturing Image Figure 2. Global Bioartificial Organ Manufacturing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bioartificial Organ Manufacturing Market Size Share 2021 VS 2025 VS 2032 Figure 4. Semi-automatic Image Figure 5. Fully Automatic Image Figure 6. Manual Image Figure 7. Global Bioartificial Organ Manufacturing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Bioartificial Organ Manufacturing Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospitals Image Figure 10. Research Institutes Image Figure 11. Laboratory Image Figure 12. Others Image Figure 13. Global Bioartificial Organ Manufacturing Market Size (US$ Million) & (2021-2032) Figure 14. Global Bioartificial Organ Manufacturing Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Bioartificial Organ Manufacturing Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Bioartificial Organ Manufacturing Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Bioartificial Organ Manufacturing Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Bioartificial Organ Manufacturing Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Bioartificial Organ Manufacturing Revenue Market Share by Type (2021-2032) Figure 21. Global Bioartificial Organ Manufacturing Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Bioartificial Organ Manufacturing Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Bioartificial Organ Manufacturing Revenue Market Share by Application (2021-2032) Figure 24. North America Bioartificial Organ Manufacturing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Bioartificial Organ Manufacturing Revenue Share by Type (2021-2032) Figure 26. North America Bioartificial Organ Manufacturing Revenue Share by Application (2021-2032) Figure 27. North America Bioartificial Organ Manufacturing Revenue Share by Country (2021-2032) Figure 28. United States Bioartificial Organ Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Bioartificial Organ Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Bioartificial Organ Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Bioartificial Organ Manufacturing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Bioartificial Organ Manufacturing Revenue Share by Type (2021-2032) Figure 33. Europe Bioartificial Organ Manufacturing Revenue Share by Application (2021-2032) Figure 34. Europe Bioartificial Organ Manufacturing Revenue Share by Country (2021-2032) Figure 35. Germany Bioartificial Organ Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Bioartificial Organ Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Bioartificial Organ Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Bioartificial Organ Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Bioartificial Organ Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Bioartificial Organ Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Bioartificial Organ Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Bioartificial Organ Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Bioartificial Organ Manufacturing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Bioartificial Organ Manufacturing Revenue Share by Type (2021-2032) Figure 45. China Bioartificial Organ Manufacturing Revenue Share by Application (2021-2032) Figure 46. Asia Bioartificial Organ Manufacturing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Bioartificial Organ Manufacturing Revenue Share by Type (2021-2032) Figure 48. Asia Bioartificial Organ Manufacturing Revenue Share by Application (2021-2032) Figure 49. Asia Bioartificial Organ Manufacturing Revenue Share by Region (2021-2032) Figure 50. Japan Bioartificial Organ Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Bioartificial Organ Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Bioartificial Organ Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Bioartificial Organ Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Bioartificial Organ Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Bioartificial Organ Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Bioartificial Organ Manufacturing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Bioartificial Organ Manufacturing Revenue Share by Type (2021-2032) Figure 58. SAMEA Bioartificial Organ Manufacturing Revenue Share by Application (2021-2032) Figure 59. SAMEA Bioartificial Organ Manufacturing Revenue Share by Country (2021-2032) Figure 60. Brazil Bioartificial Organ Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Bioartificial Organ Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Bioartificial Organ Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Bioartificial Organ Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Bioartificial Organ Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Bioartificial Organ Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Bioartificial Organ Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Bioartificial Organ Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Bioartificial Organ Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Bioartificial Organ Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Bioartificial Organ Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Semi-automatic
  • Fully Automatic
  • Manual
Applications
  • Hospitals
  • Research Institutes
  • Laboratory
  • Others
Companies covered
  • B. Braun
  • Boston Scientific Corporation
  • ABIOMED
  • Asahi Kasei Corporation
  • Berlin Heart
  • CARMAT
  • Jarvik Heart
  • SynCardia Systems
  • Nipro Europe Group Companies
  • Organovo Holdings
  • NexImmune
  • Diabeloop
  • Admetsys
  • Defymed
  • Pancreum
  • Beta Bionics
  • Integra LifeSciences
  • Wake Forest Institute for Regenerative Medicine (WFIRM)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Bioartificial Organ Manufacturing Market by Type
  3. 1.2.1 Global Bioartificial Organ Manufacturing Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Semi-automatic
  5. 1.2.3 Fully Automatic
  6. 1.2.4 Manual
  7. 1.3 Bioartificial Organ Manufacturing Market by Application
  8. 1.3.1 Global Bioartificial Organ Manufacturing Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospitals
  10. 1.3.3 Research Institutes
  11. 1.3.4 Laboratory
  12. 1.3.5 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Bioartificial Organ Manufacturing Market Dynamics
  1. 2.1 Bioartificial Organ Manufacturing Industry Trends
  2. 2.2 Bioartificial Organ Manufacturing Industry Drivers
  3. 2.3 Bioartificial Organ Manufacturing Industry Opportunities and Challenges
  4. 2.4 Bioartificial Organ Manufacturing Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Bioartificial Organ Manufacturing Market Perspective (2021-2032)
  2. 3.2 Global Bioartificial Organ Manufacturing Growth Trends by Region
  3. 3.2.1 Global Bioartificial Organ Manufacturing Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Bioartificial Organ Manufacturing Market Size by Region (2021-2026)
  5. 3.2.3 Global Bioartificial Organ Manufacturing Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Bioartificial Organ Manufacturing Revenue by Players
  2. 4.1.1 Global Bioartificial Organ Manufacturing Revenue by Players (2021-2026)
  3. 4.1.2 Global Bioartificial Organ Manufacturing Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Bioartificial Organ Manufacturing Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Bioartificial Organ Manufacturing Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Bioartificial Organ Manufacturing Key Players Headquarters & Area Served
  7. 4.4 Global Bioartificial Organ Manufacturing Players, Product Type & Application
  8. 4.5 Global Bioartificial Organ Manufacturing Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Bioartificial Organ Manufacturing Market CR5 and HHI
  11. 4.6.3 2025 Bioartificial Organ Manufacturing Tier 1, Tier 2, and Tier 3
5 Bioartificial Organ Manufacturing Market Size by Type
  1. 5.1 Global Bioartificial Organ Manufacturing Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Bioartificial Organ Manufacturing Revenue by Type (2021-2032)
  3. 5.3 Global Bioartificial Organ Manufacturing Revenue Market Share by Type (2021-2032)
6 Bioartificial Organ Manufacturing Market Size by Application
  1. 6.1 Global Bioartificial Organ Manufacturing Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Bioartificial Organ Manufacturing Revenue by Application (2021-2032)
  3. 6.3 Global Bioartificial Organ Manufacturing Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 B. Braun
  2. 7.1.1 B. Braun Company Information
  3. 7.1.2 B. Braun Business Overview
  4. 7.1.3 B. Braun Bioartificial Organ Manufacturing Revenue and Gross Margin (2021-2026)
  5. 7.1.4 B. Braun Bioartificial Organ Manufacturing Product Portfolio
  6. 7.1.5 B. Braun Recent Developments
  7. 7.2 Boston Scientific Corporation
  8. 7.2.1 Boston Scientific Corporation Company Information
  9. 7.2.2 Boston Scientific Corporation Business Overview
  10. 7.2.3 Boston Scientific Corporation Bioartificial Organ Manufacturing Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Boston Scientific Corporation Bioartificial Organ Manufacturing Product Portfolio
  12. 7.2.5 Boston Scientific Corporation Recent Developments
  13. 7.3 ABIOMED
  14. 7.3.1 ABIOMED Company Information
  15. 7.3.2 ABIOMED Business Overview
  16. 7.3.3 ABIOMED Bioartificial Organ Manufacturing Revenue and Gross Margin (2021-2026)
  17. 7.3.4 ABIOMED Bioartificial Organ Manufacturing Product Portfolio
  18. 7.3.5 ABIOMED Recent Developments
  19. 7.4 Asahi Kasei Corporation
  20. 7.4.1 Asahi Kasei Corporation Company Information
  21. 7.4.2 Asahi Kasei Corporation Business Overview
  22. 7.4.3 Asahi Kasei Corporation Bioartificial Organ Manufacturing Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Asahi Kasei Corporation Bioartificial Organ Manufacturing Product Portfolio
  24. 7.4.5 Asahi Kasei Corporation Recent Developments
  25. 7.5 Berlin Heart
  26. 7.5.1 Berlin Heart Company Information
  27. 7.5.2 Berlin Heart Business Overview
  28. 7.5.3 Berlin Heart Bioartificial Organ Manufacturing Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Berlin Heart Bioartificial Organ Manufacturing Product Portfolio
  30. 7.5.5 Berlin Heart Recent Developments
  31. 7.6 CARMAT
  32. 7.6.1 CARMAT Company Information
  33. 7.6.2 CARMAT Business Overview
  34. 7.6.3 CARMAT Bioartificial Organ Manufacturing Revenue and Gross Margin (2021-2026)
  35. 7.6.4 CARMAT Bioartificial Organ Manufacturing Product Portfolio
  36. 7.6.5 CARMAT Recent Developments
  37. 7.7 Jarvik Heart
  38. 7.7.1 Jarvik Heart Company Information
  39. 7.7.2 Jarvik Heart Business Overview
  40. 7.7.3 Jarvik Heart Bioartificial Organ Manufacturing Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Jarvik Heart Bioartificial Organ Manufacturing Product Portfolio
  42. 7.7.5 Jarvik Heart Recent Developments
  43. 7.8 SynCardia Systems
  44. 7.8.1 SynCardia Systems Company Information
  45. 7.8.2 SynCardia Systems Business Overview
  46. 7.8.3 SynCardia Systems Bioartificial Organ Manufacturing Revenue and Gross Margin (2021-2026)
  47. 7.8.4 SynCardia Systems Bioartificial Organ Manufacturing Product Portfolio
  48. 7.8.5 SynCardia Systems Recent Developments
  49. 7.9 Nipro Europe Group Companies
  50. 7.9.1 Nipro Europe Group Companies Company Information
  51. 7.9.2 Nipro Europe Group Companies Business Overview
  52. 7.9.3 Nipro Europe Group Companies Bioartificial Organ Manufacturing Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Nipro Europe Group Companies Bioartificial Organ Manufacturing Product Portfolio
  54. 7.9.5 Nipro Europe Group Companies Recent Developments
  55. 7.10 Organovo Holdings
  56. 7.10.1 Organovo Holdings Company Information
  57. 7.10.2 Organovo Holdings Business Overview
  58. 7.10.3 Organovo Holdings Bioartificial Organ Manufacturing Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Organovo Holdings Bioartificial Organ Manufacturing Product Portfolio
  60. 7.10.5 Organovo Holdings Recent Developments
  61. 7.11 NexImmune
  62. 7.11.1 NexImmune Company Information
  63. 7.11.2 NexImmune Business Overview
  64. 7.11.3 NexImmune Bioartificial Organ Manufacturing Revenue and Gross Margin (2021-2026)
  65. 7.11.4 NexImmune Bioartificial Organ Manufacturing Product Portfolio
  66. 7.11.5 NexImmune Recent Developments
  67. 7.12 Diabeloop
  68. 7.12.1 Diabeloop Company Information
  69. 7.12.2 Diabeloop Business Overview
  70. 7.12.3 Diabeloop Bioartificial Organ Manufacturing Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Diabeloop Bioartificial Organ Manufacturing Product Portfolio
  72. 7.12.5 Diabeloop Recent Developments
  73. 7.13 Admetsys
  74. 7.13.1 Admetsys Company Information
  75. 7.13.2 Admetsys Business Overview
  76. 7.13.3 Admetsys Bioartificial Organ Manufacturing Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Admetsys Bioartificial Organ Manufacturing Product Portfolio
  78. 7.13.5 Admetsys Recent Developments
  79. 7.14 Defymed
  80. 7.14.1 Defymed Company Information
  81. 7.14.2 Defymed Business Overview
  82. 7.14.3 Defymed Bioartificial Organ Manufacturing Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Defymed Bioartificial Organ Manufacturing Product Portfolio
  84. 7.14.5 Defymed Recent Developments
  85. 7.15 Pancreum
  86. 7.15.1 Pancreum Company Information
  87. 7.15.2 Pancreum Business Overview
  88. 7.15.3 Pancreum Bioartificial Organ Manufacturing Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Pancreum Bioartificial Organ Manufacturing Product Portfolio
  90. 7.15.5 Pancreum Recent Developments
  91. 7.16 Beta Bionics
  92. 7.16.1 Beta Bionics Company Information
  93. 7.16.2 Beta Bionics Business Overview
  94. 7.16.3 Beta Bionics Bioartificial Organ Manufacturing Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Beta Bionics Bioartificial Organ Manufacturing Product Portfolio
  96. 7.16.5 Beta Bionics Recent Developments
  97. 7.17 Integra LifeSciences
  98. 7.17.1 Integra LifeSciences Company Information
  99. 7.17.2 Integra LifeSciences Business Overview
  100. 7.17.3 Integra LifeSciences Bioartificial Organ Manufacturing Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Integra LifeSciences Bioartificial Organ Manufacturing Product Portfolio
  102. 7.17.5 Integra LifeSciences Recent Developments
  103. 7.18 Wake Forest Institute for Regenerative Medicine (WFIRM)
  104. 7.18.1 Wake Forest Institute for Regenerative Medicine (WFIRM) Company Information
  105. 7.18.2 Wake Forest Institute for Regenerative Medicine (WFIRM) Business Overview
  106. 7.18.3 Wake Forest Institute for Regenerative Medicine (WFIRM) Bioartificial Organ Manufacturing Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Wake Forest Institute for Regenerative Medicine (WFIRM) Bioartificial Organ Manufacturing Product Portfolio
  108. 7.18.5 Wake Forest Institute for Regenerative Medicine (WFIRM) Recent Developments
8 North America
  1. 8.1 North America Bioartificial Organ Manufacturing Revenue (2021-2032)
  2. 8.2 North America Bioartificial Organ Manufacturing Revenue by Type (2021-2032)
  3. 8.2.1 North America Bioartificial Organ Manufacturing Revenue by Type (2021-2026)
  4. 8.2.2 North America Bioartificial Organ Manufacturing Revenue by Type (2027-2032)
  5. 8.3 North America Bioartificial Organ Manufacturing Revenue Share by Type (2021-2032)
  6. 8.4 North America Bioartificial Organ Manufacturing Revenue by Application (2021-2032)
  7. 8.4.1 North America Bioartificial Organ Manufacturing Revenue by Application (2021-2026)
  8. 8.4.2 North America Bioartificial Organ Manufacturing Revenue by Application (2027-2032)
  9. 8.5 North America Bioartificial Organ Manufacturing Revenue Share by Application (2021-2032)
  10. 8.6 North America Bioartificial Organ Manufacturing Revenue by Country
  11. 8.6.1 North America Bioartificial Organ Manufacturing Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Bioartificial Organ Manufacturing Revenue by Country (2021-2026)
  13. 8.6.3 North America Bioartificial Organ Manufacturing Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Bioartificial Organ Manufacturing Revenue (2021-2032)
  2. 9.2 Europe Bioartificial Organ Manufacturing Revenue by Type (2021-2032)
  3. 9.2.1 Europe Bioartificial Organ Manufacturing Revenue by Type (2021-2026)
  4. 9.2.2 Europe Bioartificial Organ Manufacturing Revenue by Type (2027-2032)
  5. 9.3 Europe Bioartificial Organ Manufacturing Revenue Share by Type (2021-2032)
  6. 9.4 Europe Bioartificial Organ Manufacturing Revenue by Application (2021-2032)
  7. 9.4.1 Europe Bioartificial Organ Manufacturing Revenue by Application (2021-2026)
  8. 9.4.2 Europe Bioartificial Organ Manufacturing Revenue by Application (2027-2032)
  9. 9.5 Europe Bioartificial Organ Manufacturing Revenue Share by Application (2021-2032)
  10. 9.6 Europe Bioartificial Organ Manufacturing Revenue by Country
  11. 9.6.1 Europe Bioartificial Organ Manufacturing Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Bioartificial Organ Manufacturing Revenue by Country (2021-2026)
  13. 9.6.3 Europe Bioartificial Organ Manufacturing Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Bioartificial Organ Manufacturing Revenue (2021-2032)
  2. 10.2 China Bioartificial Organ Manufacturing Revenue by Type (2021-2032)
  3. 10.2.1 China Bioartificial Organ Manufacturing Revenue by Type (2021-2026)
  4. 10.2.2 China Bioartificial Organ Manufacturing Revenue by Type (2027-2032)
  5. 10.3 China Bioartificial Organ Manufacturing Revenue Share by Type (2021-2032)
  6. 10.4 China Bioartificial Organ Manufacturing Revenue by Application (2021-2032)
  7. 10.4.1 China Bioartificial Organ Manufacturing Revenue by Application (2021-2026)
  8. 10.4.2 China Bioartificial Organ Manufacturing Revenue by Application (2027-2032)
  9. 10.5 China Bioartificial Organ Manufacturing Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Bioartificial Organ Manufacturing Revenue (2021-2032)
  2. 11.2 Asia Bioartificial Organ Manufacturing Revenue by Type (2021-2032)
  3. 11.2.1 Asia Bioartificial Organ Manufacturing Revenue by Type (2021-2026)
  4. 11.2.2 Asia Bioartificial Organ Manufacturing Revenue by Type (2027-2032)
  5. 11.3 Asia Bioartificial Organ Manufacturing Revenue Share by Type (2021-2032)
  6. 11.4 Asia Bioartificial Organ Manufacturing Revenue by Application (2021-2032)
  7. 11.4.1 Asia Bioartificial Organ Manufacturing Revenue by Application (2021-2026)
  8. 11.4.2 Asia Bioartificial Organ Manufacturing Revenue by Application (2027-2032)
  9. 11.5 Asia Bioartificial Organ Manufacturing Revenue Share by Application (2021-2032)
  10. 11.6 Asia Bioartificial Organ Manufacturing Revenue by Country
  11. 11.6.1 Asia Bioartificial Organ Manufacturing Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Bioartificial Organ Manufacturing Revenue by Country (2021-2026)
  13. 11.6.3 Asia Bioartificial Organ Manufacturing Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Bioartificial Organ Manufacturing Revenue (2021-2032)
  2. 12.2 SAMEA Bioartificial Organ Manufacturing Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Bioartificial Organ Manufacturing Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Bioartificial Organ Manufacturing Revenue by Type (2027-2032)
  5. 12.3 SAMEA Bioartificial Organ Manufacturing Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Bioartificial Organ Manufacturing Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Bioartificial Organ Manufacturing Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Bioartificial Organ Manufacturing Revenue by Application (2027-2032)
  9. 12.5 SAMEA Bioartificial Organ Manufacturing Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Bioartificial Organ Manufacturing Revenue by Country
  11. 12.6.1 SAMEA Bioartificial Organ Manufacturing Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Bioartificial Organ Manufacturing Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Bioartificial Organ Manufacturing Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst